CD70

Ongoing clinical trials and approved products targeting CD70, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.

0ongoing therapy trials
3ongoing imaging trials
0approved products

Target note

Full name
CD70
Nature
CD27 ligand of the TNF family.
Normal expression
Activated lymphocytes.
Value
A target in clear cell renal cell carcinoma and lymphomas.
Approaches
Peptides and fragments labeled with ⁶⁸Ga.
Indications explored
Renal cell carcinoma (research).
Points of caution
Early stage.

Ongoing imaging trials · 3Open in the radar →

TrialPhaseStatusSponsorCountries
CD70 tracersNCT06680089 · KidneyPhase 2RecruitingRenJi Hospital1
CD70 tracersNCT06852638 · KidneyPhase 2RecruitingRenJi Hospital1
CD70 tracersNCT06769893 · KidneyNo phaseRecruitingXijing Hospital1

Cite this page

CD70. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/cd70/ (accessed [date]).

A monitoring tool with no regulatory value: check every item at its source.